Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Published by: Global Markets Direct

Published: Sep. 28, 2009 - 87 Pages


Table of Contents


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in This Report
3.1 Drug delivery devices
3.2 Needle-free Injections
3.3 Inhalation Systems
3.4 Infusion Systems
4 Drug Delivery Devices in Asia-Pacific
4.1 Drug Delivery Devices, Asia-Pacific, Overall Revenue ($ mn), 2000-2015
4.2 Drug Delivery Devices, Asia-Pacific, Category Volume (Units), 2000-2015
4.3 Drug Delivery Devices, Asia-Pacific, Company share (2007-2008)
5 Drug Delivery Devices In Japan
5.1 Drug Delivery Devices, Japan, Overall Revenue ($ mn), 2000-2015
5.2 Drug Delivery Devices, Japan, Category Volume (Units), 2000-2015
5.3 Drug Delivery Devices, Japan, Distribution Share (2007-2008)
5.3.1 Infusion Systems Distribution Share (2007-2008)
5.3.2 Inhalation Systems Distribution Share (2007-2008)
5.3.3 Needle Free Injections Distribution Share (2007-2008)
5.4 Drug Delivery Devices, Japan, Company Share (2007-2008)
5.4.1 Drug Delivery Devices, Japan, Company Share (2007-2008)
5.4.2 Infusion Systems, Japan, Company Share (2007-2008)
5.4.3 Inhalation Systems, Japan, Company Share (2007-2008)
6 Drug Delivery Devices In China
6.1 Drug Delivery Devices, China, Overall Revenue ($ mn), 2000-2015
6.2 Drug Delivery Devices, China, Category Volume (Units), 2000-2015
6.3 Drug Delivery Devices, China, Distribution Share (2007-2008)
6.3.1 Infusion Systems Distribution Share (2007-2008)
6.3.2 Inhalation Systems Distribution Share (2007-2008)
6.4 Drug Delivery Devices, China, Company Share (2007-2008)
6.4.1 Drug Delivery Devices, China, Company Share (2007-2008)
6.4.2 Infusion Systems, China, Company Share (2007-2008)
6.4.3 Inhalation Systems, China, Company Share (2007-2008)
7 Drug Delivery Devices In Australia
7.1 Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015
7.2 Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015
7.3 Drug Delivery Devices, Australia, Distribution Share (2007-2008)
7.3.1 Infusion Systems Distribution Share (2007-2008)
7.3.2 Inhalation Systems Distribution Share (2007-2008)
7.4 Drug Delivery Devices, Australia, Company Share (2007-2008)
7.4.1 Drug Delivery Devices, Australia, Company Share (2007-2008)
7.4.2 Infusion Systems, Australia, Company Share (2007-2008)
7.4.3 Inhalation Systems, Australia, Company Share (2007-2008)
8 Drug Delivery Devices In India
8.1 Drug Delivery Devices, India, Overall Revenue ($ mn), 2000-2015
8.2 Drug Delivery Devices, India, Category Volume (Units), 2000-2015
8.3 Drug Delivery Devices, India, Distribution Share (2007-2008)
8.3.1 Infusion Systems Distribution Share (2007-2008)
8.3.2 Inhalation Systems Distribution Share (2007-2008)
8.4 Drug Delivery Devices, India, Company Share (2007-2008)
8.4.1 Drug Delivery Devices, India, Company Share (2007-2008)
8.4.2 Infusion Systems, India, Company Share (2007-2008)
8.4.3 Inhalation Systems, India, Company Share (2007-2008)
9 Overview of Key Companies in Asia-Pacific Drug Delivery Devices Market
9.1 AstraZeneca PLC
9.1.1 Company Overview
9.2 Boehringer Ingelheim GmbH
9.2.1 Company Overview
9.3 Baxter International Inc.
9.3.1 Company Overview
9.4 Novartis AG
9.4.1 Company Overview
9.5 Terumo Corporation
9.5.1 Company Overview
9.5.2 Terumo Corporation Pipeline Products
9.5.2.1 Terumo Corporation Pipeline Products By Equipment Type
9.5.2.2 Terumo Corporation Pipeline Products By Development Stage
9.5.2.3 Terumo Corporation Pipeline Products By Therapy Area
9.5.2.4 Terumo Corporation Pipeline Products By Clinical Trials
9.5.2.5 Terumo Corporation Pipeline Products By News Summary
9.6 Cardinal Health, Inc.
9.6.1 Company Overview
9.7 NIPRO CORPORATION
9.7.1 Company Overview
9.8 GlaxoSmithKline plc
9.8.1 Company Overview
9.9 B. Braun Melsungen AG
9.9.1 Company Overview
9.10 Smiths Medical
9.10.1 Company Overview
9.11 Fresenius Kabi AG
9.11.1 Company Overview
9.12 JMS CO., LTD.
9.12.1 Company Overview
9.13 Bioject Medical Technologies Inc.
9.13.1 Company Overview
9.13.2 Bioject Medical Technologies Inc. Pipeline Products
9.13.2.1 Bioject Medical Technologies Inc. Pipeline Products By Equipment Type
9.13.2.2 Bioject Medical Technologies Inc. Pipeline Products By Development Stage
9.13.2.3 Bioject Medical Technologies Inc. Pipeline Products By Therapy Area
9.13.2.4 Bioject Medical Technologies Inc. Pipeline Products By Clinical Trials
9.13.2.5 Bioject Medical Technologies Inc. Pipeline Products By News Summary
9.14 Consort Medical plc
9.14.1 Company Overview
9.14.2 Consort Medical plc Pipeline Products
9.14.2.1 Bespak plc Pipeline Products By Equipment Type
9.14.2.2 Bespak plc Pipeline Products By Development Stage
9.14.2.3 Bespak plc Pipeline Products By Therapy Area
9.15 Hospira, Inc.
9.16 Daiken Medical Co., Ltd.
9.16.1 Company Overview
9.17 Trivitron Group of Companies
9.17.1 Company Overview
9.18 Plenum Technologies Private Limited
9.18.1 Company Overview
10 Financial Deals Landscape
10.1 Partnerships
10.1.1 BioChemics Signs An Agreement With Pacific Pharmaceutical
10.1.2 Novartis Terminates Its Licensing Agreement With NexMed
10.1.3 Echo Therapeutics Enters Into Licensing Agreement With HANDOK Pharmaceuticals
10.1.4 Teikoku Pharma Enters Into An Agreement With Eisai
11 Recent Developments
11.1 Strategy and Business Planning
11.1.1 May 18, 2009: 3M CUNO Establishes Filter Validation Lab
11.1.2 May 17, 2009: Piramal Life Sciences Plans INR 2 Billion Investment In R&D
12 Appendix
12.1 Global Markets Direct Research Methodology
12.2 Secondary Research
12.3 Primary Research
12.4 Models
12.5 Forecasts
12.6 Expert Panel Validation
12.7 Currency Conversion
12.8 Contact Us
12.9 Disclaimer
1.1 List of Tables
Table 1: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($ mn), 2000-2015
Table 2: Drug Delivery Devices, Asia-Pacific, Cross-Category Analysis, 2000-2015
Table 3: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($ mn), Historic, 2000-2008
Table 4: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($ mn), Forecast, 2008-2015
Table 5: Drug Delivery Devices, Asia-Pacific, Category Volume (Units), 2000-2015
Table 6: Drug Delivery Devices, Asia-Pacific, Category Volume (Units), Historic, 2000-2008
Table 7: Drug Delivery Devices, Asia-Pacific, Category Volume (Units), Forecast, 2008-2015
Table 8: Drug Delivery Devices, Asia-Pacific, Company share by Revenue ($ mn), 2007-2008
Table 9: Drug Delivery Devices, Japan, Overall Revenue ($ mn), 2000-2015
Table 10: Drug Delivery Devices, Japan, Overall Revenue ($ mn), Historic, 2000-2008
Table 11: Drug Delivery Devices, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
Table 12: Drug Delivery Devices, Japan, Category Volume (Units), 2000-2015
Table 13: Drug Delivery Devices, Japan, Category Volume (Units), Historic, 2000-2008
Table 14: Drug Delivery Devices, Japan, Category Volume (Units), Forecast, 2008-2015
Table 15: Infusion Systems, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 16: Inhalation Systems, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 17: Needle Free Injections, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 18: Drug Delivery Devices, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 19: Infusion Systems, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 20: Inhalation Systems, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 21: Drug Delivery Devices, China, Overall Revenue ($ mn), 2000-2015
Table 22: Drug Delivery Devices, China, Overall Revenue ($ mn), Historic, 2000-2008
Table 23: Drug Delivery Devices, China, Overall Revenue ($ mn), Forecast, 2008-2015
Table 24: Drug Delivery Devices, China, Category Volume (Units), 2000-2015
Table 25: Drug Delivery Devices, China, Category Volume (Units), Historic, 2000-2008
Table 26: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2008-2015
Table 27: Infusion Systems, China, Distribution Share by Revenue ($mn), 2007-2008
Table 28: Inhalation Systems, China, Distribution Share by Revenue ($mn), 2007-2008
Table 29: Drug Delivery Devices, China, Company Share by Revenue ($ mn), 2007-2008
Table 30: Infusion Systems, China, Company Share by Revenue ($ mn), 2007-2008
Table 31: Inhalation Systems, China, Company Share by Revenue ($ mn), 2007-2008
Table 32: Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015
Table 33: Drug Delivery Devices, Australia, Overall Revenue ($ mn), Historic, 2000-2008
Table 34: Drug Delivery Devices, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
Table 35: Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015
Table 36: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2000-2008
Table 37: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2008-2015
Table 38: Infusion Systems, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 39: Inhalation Systems, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 40: Drug Delivery Devices, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 41: Infusion Systems, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 42: Inhalation Systems, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 43: Drug Delivery Devices, India, Overall Revenue ($ mn), 2000-2015
Table 44: Drug Delivery Devices, India, Overall Revenue ($ mn), Historic, 2000-2008
Table 45: Drug Delivery Devices, India, Overall Revenue ($ mn), Forecast, 2008-2015
Table 46: Drug Delivery Devices, India, Category Volume (Units), 2000-2015
Table 47: Drug Delivery Devices, India, Category Volume (Units), Historic, 2000-2008
Table 48: Drug Delivery Devices, India, Category Volume (Units), Forecast, 2008-2015
Table 49: Infusion Systems, India, Distribution Share by Revenue ($mn), 2007-2008
Table 50: Inhalation Systems, India, Distribution Share by Revenue ($mn), 2007-2008
Table 51: Drug Delivery Devices, India, Company Share by Revenue ($ mn), 2007-2008
Table 52: Infusion Systems, India, Company Share by Revenue ($ mn), 2007-2008
Table 53: Inhalation Systems, India, Company Share by Revenue ($ mn), 2007-2008
Table 54: Terumo Corporation Pipeline Products by Equipment Type
Table 55: Terumo Corporation Pipeline Products By Development Stage
Table 56: Terumo Corporation Pipeline Products By Therapy Area
Table 57: Terumo Corporation Pipeline Products By Clinical Trials
Table 58: Terumo Corporation Pipeline Products By News Summary
Table 59: Bioject Medical Technologies Inc. Pipeline Products by Equipment Type
Table 60: Bioject Medical Technologies Inc. Pipeline Products By Development Stage
Table 61: Bioject Medical Technologies Inc. Pipeline Products By Therapy Area
Table 62: Bioject Medical Technologies Inc. Pipeline Products By Clinical Trials
Table 63: Bioject Medical Technologies Inc. Pipeline Products By News Summary
Table 64: Bespak plc Pipeline Products by Equipment Type
Table 65: Bespak plc Pipeline Products By Development Stage
Table 66: Bespak plc Pipeline Products By Therapy Area
Table 67: BioChemics Signs An Agreement With Pacific Pharmaceutical
Table 68: Novartis Terminates Its Licensing Agreement With NexMed
Table 69: Echo Therapeutics Enters Into Licensing Agreement With HANDOK Pharmaceuticals
Table 70: Teikoku Pharma Enters Into An Agreement With Eisai
Table 71: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures
Figure 1 Drug Delivery Devices, Asia-Pacific, Overall Revenue ($ mn), 2000-2015
Figure 2 Drug Delivery Devices, Asia-Pacific, Cross-Category Analysis, 2000-2015
Figure 3 Drug Delivery Devices, Asia-Pacific, Overall Revenue ($ mn), Historic, 2000-2008
Figure 4 Drug Delivery Devices, Asia-Pacific, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 5 Drug Delivery Devices, Asia-Pacific, Category Volume (Units), 2000-2015
Figure 6 Drug Delivery Devices, Asia-Pacific, Category Volume (Units), Historic, 2000-2008
Figure 7 Drug Delivery Devices, Asia-Pacific, Category Volume (Units), Forecast, 2008-2015
Figure 8 Drug Delivery Devices, Asia-Pacific, Company share (%), 2008
Figure 9 Drug Delivery Devices, Japan, Overall Revenue ($ mn), 2000-2015
Figure 10 Drug Delivery Devices, Japan, Overall Revenue ($ mn), Historic, 2000-2008
Figure 11 Drug Delivery Devices, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 12 Drug Delivery Devices, Japan, Category Volume (Units), 2000-2015
Figure 13 Drug Delivery Devices, Japan, Category Volume (Units), Historic, 2000-2008
Figure 14 Drug Delivery Devices, Japan, Category Volume (Units), Forecast, 2008-2015
Figure 15 Drug Delivery Devices, Japan, Company Share (%), 2008
Figure 16 Infusion Systems, Japan, Company Share (%), 2008
Figure 17 Inhalation Systems, Japan, Company Share (%), 2008
Figure 18 Drug Delivery Devices, China, Overall Revenue ($ mn), 2000-2015
Figure 19 Drug Delivery Devices, China, Overall Revenue ($ mn), Historic, 2000-2008
Figure 20 Drug Delivery Devices, China, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 21 Drug Delivery Devices, China, Category Volume (Units), 2000-2015
Figure 22 Drug Delivery Devices, China, Category Volume (Units), Historic, 2000-2008
Figure 23 Drug Delivery Devices, China, Category Volume (Units), Forecast, 2008-2015
Figure 24 Drug Delivery Devices, China, Company Share (%), 2008
Figure 25 Infusion Systems, China, Company Share (%), 2008
Figure 26 Inhalation Systems, China, Company Share (%), 2008
Figure 27 Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015
Figure 28 Drug Delivery Devices, Australia, Overall Revenue ($ mn), Historic, 2000-2008
Figure 29 Drug Delivery Devices, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 30 Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015
Figure 31 Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2000-2008
Figure 32 Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2008-2015
Figure 33 Drug Delivery Devices, Australia, Company Share (%), 2008
Figure 34 Infusion Systems, Australia, Company Share (%), 2008
Figure 35 Inhalation Systems, Australia, Company Share (%), 2008
Figure 36 Drug Delivery Devices, India, Overall Revenue ($ mn), 2000-2015
Figure 37 Drug Delivery Devices, India, Overall Revenue ($ mn), Historic, 2000-2008
Figure 38 Drug Delivery Devices, India, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 39 Drug Delivery Devices, India, Category Volume (Units), 2000-2015
Figure 40 Drug Delivery Devices, India, Category Volume (Units), Historic, 2000-2008
Figure 41 Drug Delivery Devices, India, Category Volume (Units), Forecast, 2008-2015
Figure 42 Drug Delivery Devices, India, Company Share (%), 2008
Figure 43 Infusion Systems, India, Company Share (%), 2008
Figure 44 Inhalation Systems, India, Company Share (%), 2008
Figure 45 Global Markets Direct Methodology

Abstract

Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Asia Pacific drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Asia Pacific

Scope
  • The report provides information on the drug delivery devices market in the Asia Pacific.
  • Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
  • Total revenues, products sold and end users.
  • Market shares of all the key competitors such as AstraZeneca International plc, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Novartis AG, and Terumo Corporation.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the drug delivery devices market in Asia Pacific.
  • Evaluate and compare the attractiveness of the market in the region.
  • Identify growth segments and opportunities in each industry sector within the region.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
  • Analyze the competitiveness of the market in the region and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the region.
  • Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the region.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009